ArticleFASEB bioAdvances2019

Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe-mediated steatosis prevention and recovery.

Yu Toyoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.